Skip to content
AnalystLens

COCA COLA CO 8-K Report, Financial Results (Apr 29, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed April 29, 2025
Period End
April 29, 2025
Security
KO
In the record · 2016–202610-K1110-Q338-K143

KO filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 143 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Aug ’22Aug ’22
  2. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 8-K filed April 29, 2025. Cited figures are marked; the original filing is the authoritative source.

The Coca-Cola Company reported first quarter 2025 results on April 29, 2025, with a headline split between strong operating profit growth and weak cash flow.

Net revenues declined 2% to $11.1 billiona, reflecting a 5-point currency headwind and the impact of refranchising bottling operations. Excluding currency and structural changes, organic revenues grew 6%, driven by 5% price/mix and 2% unit case volume growth. Reported operating income rose 71% to $3.66 billion, but this was flattered by one-time items, including a $331 million gain on the partial sale of its Coca-Cola Europacific Partners stake and the absence of a prior-year $760 million BODYARMOR impairment.

On a comparable currency-neutral basis, operating income grew 10%, and comparable operating margin expanded to 33.8% from 32.4%. Reported EPS rose 5% to $0.77b, while comparable EPS grew 1% to $0.73, with a 5-point currency headwind. Management also revised its full-year outlook: comparable currency-neutral EPS growth is now 7% to 9%, but reported comparable EPS growth is guided to only 2% to 3% after a 5% to 6% currency headwind.

Organic revenue growth guidance of 5% to 6% was reaffirmed, and comparable net revenue is now expected to face a 2% to 3% currency headwind. Cash flow was the main concern in the quarter. Operating cash flow was negative $5.2 billionc, and free cash flow was negative $5.5 billion, primarily due to a $6.1 billion final milestone payment to fairlife's former owners.

Excluding that payment, free cash flow was $558 milliond. Management still expects full-year free cash flow excluding the fairlife payment of approximately $9.5 billion. Total debt rose sharply, with loans and notes payable increasing to $5.4 billion from $1.5 billion, and cash and short-term investments declined to $12.0 billion.

Key Highlights

  1. Net revenues fell 2% to $11.1 billion, but organic revenues grew 6%, led by 5% price/mix and 2% unit case volume growth.
  2. Reported operating income grew 71% to $3.66 billion, though this was boosted by a $331 million gain on the Coca-Cola Europacific Partners stake sale and the lapping of a $760 million prior-year impairment; comparable currency-neutral operating income grew 10%.
  3. Reported EPS grew 5% to $0.77; comparable EPS grew 1% to $0.73, reflecting a 5-point currency headwind.
  4. Operating cash flow was negative $5.2 billion and free cash flow was negative $5.5 billion, driven by the $6.1 billion fairlife contingent consideration payment; excluding it, free cash flow was $558 million.
  5. Full-year guidance: comparable currency-neutral EPS growth raised to 7% to 9%, but reported comparable EPS growth reduced to 2% to 3% due to a 5% to 6% currency headwind; organic revenue growth of 5% to 6% reaffirmed.
  6. Full-year free cash flow excluding the fairlife payment is still expected at approximately $9.5 billion, and the underlying effective tax rate is projected at 20.8%, up from 18.6%.
  7. Short-term borrowings increased to $5.4 billion from $1.5 billion, and cash plus short-term investments declined to $12.0 billion from $12.8 billion.

Frequently Asked Questions

  1. Why did reported operating income rise 71% if revenue declined?

    The increase was mostly due to non-recurring items. Q1 2024 included a $760 million BODYARMOR impairment and several refranchising-related gains, while Q1 2025 included a $331 million gain from selling part of the Coca-Cola Europacific Partners stake. Excluding these items and currency effects, comparable currency-neutral operating income grew 10%.

  2. Is the negative free cash flow a concern for investors?

    The negative free cash flow of $5.5 billion was a one-time effect of the $6.1 billion final fairlife contingent consideration payment made in March 2025. Excluding that payment, free cash flow was $558 million. The company still expects roughly $9.5 billion of free cash flow excluding the payment for full-year 2025, though investors should monitor working capital, since net change in operating assets and liabilities was a $8.5 billion outflow in the quarter.

  3. Did the company change its full-year outlook?

    Partially. Comparable currency-neutral EPS growth was raised to 7% to 9%, but reported comparable EPS growth was lowered to 2% to 3% because of a larger 5% to 6% currency headwind. Organic revenue growth of 5% to 6%, the 2025 free cash flow estimate, and the $2.88 2024 comparable EPS base were unchanged. The company also flagged new risks from global trade dynamics, which it currently considers manageable.

  4. What is the status of the IRS tax dispute?

    The company's underlying effective tax rate guidance of 20.8% excludes the potential impact of its ongoing tax litigation with the U.S. Internal Revenue Service. If the company does not prevail, it could face additional tax and interest liabilities. The filing did not quantify this exposure in the quarterly results.